Trevena, Inc. (TRVN) Financials

TRVN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 45.1 million 41.6 million
2023-06-30 38.9 million 29.1 million
2023-03-31 38.3 million 28.1 million
2022-12-31 48.7 million 33.1 million

TRVN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.9 million 689000
2023-06-30 -7.3 million 702000
2023-03-31 -10.9 million 806000
2022-12-31 -10.6 million 749000

TRVN Net Income

No data available :(

TRVN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 35.0 million - 5.7 million
2023-06-30 28.1 million - 5.9 million
2023-03-31 27.4 million - 6.1 million
2022-12-31 38.3 million - 6.3 million

TRVN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 14.0 million
2023-06-30 11.6 million
2023-03-31 9.6 million
2022-12-31 9.6 million

TRVN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 4.3 million 4.6 million -
2023-06-30 20000 4.0 million 5.1 million -
2023-03-31 - 3.9 million 6.1 million -
2022-12-31 27972 3.4 million 21.3 million 15.6 million

TRVN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 180000 175000
2023-06-30 3.0 million 88000
2023-03-31 6000 127000
2022-12-31 - 228000

TRVN

Price: $0.41

52 week price:
0.30
3.28

Earnings Per Share: -3.16 USD

P/E Ratio: -0.10

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 42100

Ebitda: -15.1 million

Market Capitalization: 7.0 million

Links: